Correlation Between 70082LAB3 and VTv Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 70082LAB3 and VTv Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 70082LAB3 and VTv Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US70082LAB36 and vTv Therapeutics, you can compare the effects of market volatilities on 70082LAB3 and VTv Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 70082LAB3 with a short position of VTv Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 70082LAB3 and VTv Therapeutics.

Diversification Opportunities for 70082LAB3 and VTv Therapeutics

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between 70082LAB3 and VTv is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding US70082LAB36 and vTv Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on vTv Therapeutics and 70082LAB3 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US70082LAB36 are associated (or correlated) with VTv Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of vTv Therapeutics has no effect on the direction of 70082LAB3 i.e., 70082LAB3 and VTv Therapeutics go up and down completely randomly.

Pair Corralation between 70082LAB3 and VTv Therapeutics

Assuming the 90 days trading horizon US70082LAB36 is expected to generate 9.45 times more return on investment than VTv Therapeutics. However, 70082LAB3 is 9.45 times more volatile than vTv Therapeutics. It trades about 0.06 of its potential returns per unit of risk. vTv Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  7,100  in US70082LAB36 on August 30, 2024 and sell it today you would earn a total of  1,438  from holding US70082LAB36 or generate 20.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy43.35%
ValuesDaily Returns

US70082LAB36  vs.  vTv Therapeutics

 Performance 
       Timeline  
US70082LAB36 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in US70082LAB36 are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 70082LAB3 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
vTv Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in vTv Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, VTv Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

70082LAB3 and VTv Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 70082LAB3 and VTv Therapeutics

The main advantage of trading using opposite 70082LAB3 and VTv Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 70082LAB3 position performs unexpectedly, VTv Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VTv Therapeutics will offset losses from the drop in VTv Therapeutics' long position.
The idea behind US70082LAB36 and vTv Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes